Expression of multiple myeloma associated markers in bone marrow spicules using a novel immunohistochemical technique

Area of Science:

• Hematopathology
• Biomarker Analysis
• Immunohistochemistry

Background:

• Immunohistochemistry (IHC) is crucial for diagnosing and prognosing hematological malignancies like multiple myeloma (MM).
• Standard bone marrow (BM) biopsy processing involves decalcification, which can damage protein epitopes, hindering IHC analysis.
• Accurate detection of MM biomarkers in BM biopsies is essential for patient management.

Purpose of the Study:

• To develop a novel BM sample processing technique for enhanced IHC detection of MM biomarkers.
• To overcome limitations associated with decalcification in traditional BM biopsy processing.
• To establish a reliable and consistent IHC assay for MM protein markers.

Main Methods:

• A new technique was developed to process BM spicule samples into a fibrin clot matrix.
• This method avoids the harsh decalcification step required for BM core biopsies.
• Paired BM spicule-clot and BM core biopsies from MM patients were analyzed using six MM-related antibodies.

Main Results:

• The novel fibrin clot method enables IHC detection of MM protein markers.
• This technique circumvents epitope damage caused by decalcification.
• Consistent and reliable results were achieved using the new BM processing method.

Conclusions:

• The fibrin clot matrix technique offers a superior alternative for processing BM samples for IHC analysis in multiple myeloma.
• This method preserves protein epitopes, allowing for accurate detection of MM biomarkers.
• The developed assay provides a consistent and reliable tool for MM diagnosis and research.